Decoding the prognostic landscape of LUAD: the interplay between N6-methyladenosine modification and immune microenvironment
This risk score system shows promise for prognostic prediction and the development of personalized treatment strategies for LUAD patients.
Authors
- Xiang Xu (ORCID: https://orcid.org/0000-0002-1026-2210)
- Quan Chen (ORCID: https://orcid.org/0000-0003-4436-3471)
- Luoquan Ao
- Yuchuan Yuan (ORCID: https://orcid.org/0000-0002-8289-7813)
- Weijun Wan (ORCID: https://orcid.org/0000-0002-4606-8110)
- Yanli Xiong (ORCID: https://orcid.org/0000-0002-1639-103X)
- Wei Guo (ORCID: https://orcid.org/0000-0002-3886-992X)
- Xiang Ao (ORCID: https://orcid.org/0000-0002-6474-2025)
- Juan Li (ORCID: https://orcid.org/0000-0001-7870-4081)
- Di Lu (ORCID: https://orcid.org/0000-0002-8724-3739)
- Xiaofeng Wu (ORCID: https://orcid.org/0000-0003-4501-1101)
- Wei Xing
- Qing Zhao
- Lu Tang
Institutions
- Army Medical University (CN)
- Kunming Medical University (CN)
- Daping Hospital (CN)
- Xinqiao Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-12-10
- DOI
- https://doi.org/10.3389/fimmu.2024.1514497
- Citations
- 2
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.47
Funders
- National Natural Science Foundation of China
- Chongqing Science and Technology Commission
- Natural Science Foundation of Tibet Autonomous Region